Top 25 Biotechnology Startup Investors in Estonia (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Prototron
VC Fund
|
3 | Estonia, Finland, Germany | Pre-Seed, Grant, Seed | Software, Manufacturing, Energy | $4k–$66k |
|
Enterprise Estonia
VC Fund
|
3 | Estonia | Grant, Seed, Pre-Seed | Biotechnology, Software, Mobile Apps | $17k–$4.3M |
|
Nordic Foodtech VC
VC Fund
|
3 | Finland, Denmark, Sweden | Seed, Pre-Seed, Series A | Biotechnology, Food and Beverage, Life Science | $610k–$18M |
|
Voima Ventures
VC Fund
|
2 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $464k–$30M |
|
Crosslight Partners
VC Fund
|
1 | Sweden, Estonia | Seed, Venture - Series Unknown | Biotechnology, Medical, Life Science | |
|
Hatcher+
VC Fund
|
1 | United States, Italy, Australia | Pre-Seed, Seed, Convertible Note | Software, Information Technology, Health Care | $50k–$1.5M |
|
Andreas Henn Otsmaa
Angel
|
1 | Estonia | Seed | Genetics, Biotechnology | |
|
Specialist VC
VC Fund
|
1 | Estonia, United Kingdom, Finland | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $240k–$4.6M |
|
2C Ventures
VC Fund
|
1 | Estonia, Finland, Italy | Pre-Seed, Seed | Software, Renewable Energy, SaaS | $1M–$4.2M |
|
Arti Kütt
Angel
|
1 | Estonia, United Kingdom | Seed, Angel, Pre-Seed | Artificial Intelligence, Mobile, Software | |
|
Domain Associates
VC Fund
|
1 | United States, Canada, Israel | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $3.8M–$60M |
|
Ivo Remmelg
Angel
|
1 | Estonia, Latvia, Norway | Seed, Angel, Pre-Seed | Mobile, Sports, FinTech | |
|
Peep Vain
Angel
|
1 | Estonia | Seed, Angel | Software, Genetics, Recruiting | $801k–$2M |
|
SOSV
VC Fund
|
1 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
UniTartu Ventures
VC Fund
|
1 | Estonia | Pre-Seed, Seed | Biotechnology, Nanotechnology | $399k–$4.3M |
|
Siim Sikkut
Angel
|
1 | Estonia | Pre-Seed | Biotechnology | |
|
Hugues Flament
Angel
|
1 | Estonia | Pre-Seed | Biotechnology | |
|
Johnson & Johnson Development Corporation
VC Fund
|
1 | United States, United Kingdom, Canada | Series C, Series B, Series A | Health Care, Biotechnology, Medical | $3M–$49M |
|
Johanna Britt Berzin
Angel
|
1 | Estonia | Pre-Seed | Biotechnology | |
|
AS AMALFI
Angel
|
1 | Estonia | Pre-Seed | Biotechnology | |
|
European Investment Bank
VC Fund
|
1 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Energy, Health Care | $8.7M–$587M |
|
Robert Laud
Angel
|
1 | Estonia | Pre-Seed | Biotechnology | |
|
Aare Kurist
Angel
|
1 | Estonia | Seed | Genetics, Biotechnology | |
|
Estonian Research Council
VC Fund
|
1 | Estonia | Seed | Biotechnology | |
|
Timo Rein
Angel
|
1 | Estonia, Finland, United Kingdom | Seed, Angel, Convertible Note | Software, Recruiting, Human Resources | $136k–$2M |
| Access all 51 investors in Estonia Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Prototron is a start-up fund that gives money to teams for turning their great ideas into the first working prototype. Founded in 2012 by Swedbank, Tallinn Technical University and Tallinn Science Park Tehnopol. We finance teams with high growth potential in areas of Greentech, Electronics, Mechatronics and ICT. We run 3-4 rounds of financingevery year. During last 5 years we've funded 58 startups with over 470'000€ in cash + coaching/incubation services. Our protfolio has generated >4,5 M€ revenue and raised >17'000'000€ capital. These results make Prototron the most productive pre-seed fund in Estonia. Do you want to be part of the success? We seek for: *) New start-up teams who need money for building a prototype. Apply for funding: www.prototron.ee *) Additional partners who want to be part of Estonia's next success stories.
Show more...Investment focus
- Industry: Software, Manufacturing, Energy
- Stage:Pre-Seed, Grant, Seed
- Geography: Estonia, Finland, Germany
Investor stats
- Total investments: 55
- Round size: Seed $4k–$13k; Grant $5.3k–$24k; Pre-Seed $6.2k–$66k
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Parcelsea — Parcelsea is a technology firm that provides e-commerce users and last-mile delivery service providers with an open network platform. The goal is to create a smart mailbox that is user-friendly and secure for everyone.
- RAIKU — RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm tonature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.
- Jälle Technologies — Jälle Technologies create advanced recycling technologies that transform battery waste into high-value resources.
Enterprise Estonia (EAS), established in 2000, promotes business and regional development in Estonia. Enterprise Estonia is one of the largest institutions within the national support system for entrepreneurship, providing financial assistance, advisory, cooperation opportunities and training for entrepreneurs, research establishments, public andthird sector.
Show more...Investment focus
- Industry: Biotechnology, Software, Mobile Apps
- Stage:Grant, Seed, Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 29
- Round size: Seed $800k–$1.1M; Grant $17k–$2.1M; Pre-Seed $1.2M–$4.3M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- ÄIO — Innovative food technologies to replace palm oil, coconut oil and animal fats with sustainable and healthier alternatives.
- Lifeyear — Digital-first heart care. At scale.
- Rollo Robotics — 1ROLLO is the world's first commercial autonomous one-wheeled security robot. Making security services 10x cheaper, smarter, and more energy-efficient.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Life Science
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 31
- Round size: Seed $610k–$5.3M; Pre-Seed $880k–$1.9M; Series A $6.8M–$18M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely actively investing — fresh fund, raised $42M in 2024
Portfolio highlights
- Fiberdom — Fiberdom develops sustainable materials from wood fibers, focusing on plastic-free solutions. The company offers a range of compostable cutlery designed for food service and take-away applications. These products are fully recyclable and comply with European regulations, making them suitable for environmentally conscious consumers. Fiberdomemphasizes innovation in transforming wood fibers into high-performance materials, contributing to sustainability efforts in various industries. The commitment to creating eco-friendly alternatives positions Fiberdom as a key player in the materials innovation sector.
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- AquaNab Solutions — AquaNab is a biotechnology startup developing precision immunotherapies for aquaculture. The company's core platform uses alpaca-derived nanoantibodies (called AquaNabs) formulated directly into fish feed. This approach allows the therapeutic molecules to cross the fish's intestinal barrier and target pathogens from the bloodstream.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 61
- Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $108M in 2023
Portfolio highlights
- Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
- TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
- Photoncycle — The year-round solar energy system for heating and electricity
Crosslight Partners is a growth equity firm. The firm invests in the environment, healthcare, impact, and technology sectors across Europe.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, Estonia
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Gelatex Technologies — Gelatex is a Techstars-backed materials technology company that invented the fastest technology for producing bio-based nanofibers on a large scale. It is a platform technology that enables faster and up to 100 cheaper nanofiber production for applications like 3D scaffolds for tissue engineering, cultured meat, bio-based filters, eco-friendlyleather-like textile, energy storage, wound care, and many more. The technology is patent-pending and the machinery fully functional. The company was founded in 2016 and until COVID-19 pandemic developed eco-friendly leather-like textile from gelatin nanofibers, using this nanofiber production technology as part of the process. COVID-19 was a trigger to understand the wider potential of the technology which then led to pivot.The company is based in Estonia and holding incorporated in UK (2019).
- Sigrid Therapeutics — Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: United States, Italy, Australia
Investor stats
- Total investments: 194
- Round size: Seed $50k–$1.5M; Pre-Seed $50k–$1.2M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Inaam — inaam is an Australian impact investing app. Pick five themes, customise them yourself, and read every company you hold by name. A flat $10 a month subscription, and a $100 minimum to start in the fund.
- PayToMe.co — PayToMe.co offers innovative and secure payment solutions including text-to-pay, digital invoicing, and digital checkbook services.
- Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Andreas Henn Otsmaa
Show more...Investment focus
- Industry: Genetics, Biotechnology
- Stage:Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
United Angels VC is an early stage venture capital fund based in Estonia.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Estonia, United Kingdom, Finland
Investor stats
- Total investments: 72
- Round size: Seed $545k–$4.6M; Pre-Seed $240k–$2.3M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $57M in 2022
Portfolio highlights
- Copla — Simplify cybersecurity compliance with automated workflows, audits, and risk management. Our expert CISO team tailors solutions to your organization's needs.
- CyberUpgrade — Simplify cybersecurity compliance with automated workflows, audits, and risk management. Our expert CISO team tailors solutions to your organization's needs.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
2C Ventures is an early-stage venture capital firm investing in European cleantech startups driving the energy transition and circular economy. Backing visionary founders tackling climate challenges.
Show more...Investment focus
- Industry: Software, Renewable Energy, SaaS
- Stage:Pre-Seed, Seed
- Geography: Estonia, Finland, Italy
Investor stats
- Total investments: 11
- Round size: Seed $1.2M–$4.2M; Pre-Seed $1M–$2.3M
- Lead/follow: 73% lead, 27% follow
- Last fund: Likely still investing — raised $54M in 2024
Portfolio highlights
- GaltTec — GaltTec focuses on developing and marketing microtubular solid oxide fuel cells. GaltTec specializes in drones, off-grid equipment, IoT, portable devices, and space equipment. GaltTec was founded in 2022 and was headquartered in Tartu, Estonia.
- Bisly — Bisly is an Estonian startup developing intelligent building solutions.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Arti Kütt
Show more...Investment focus
- Industry: Artificial Intelligence, Mobile, Software
- Stage:Seed, Angel, Pre-Seed
- Geography: Estonia, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Patchstack — Keep your WordPress sites and JavaScript apps safe from vulnerable plugins, themes & npm packages. Protect sites with virtual patching.
- Nora AI — Nora AI offers a course for antiviral drug discovery by focusing on host cells. Nora provides scientists with profound insights into disease mechanisms and spotlights high-potential drug candidates.
- DriveX Technologies — Decrease your average claim size with AI vehicle inspection tool for CASCO pre-checks and windshield claims.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 211
- Round size: Series A $3.8M–$50M; Series B $10M–$60M; Series C $10M–$60M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $164M in 2016
Portfolio highlights
- Corthera —
- Epic Sciences — Epic Sciences develops clinical solutions that accelerate drug development and guided therapy across cancer drug indications. Epic's new AR-V7 CTC liquid biopsy test is the first clinically proven predictive test for metastatic castration-resistant prostate cancer.
- Atara Biotherapeutics — Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases.
Ivo Remmelg is a Venture Partner at Superhero Capital and the Founding Partner of NestCap. Ivo Remmelgs, President of the Estonian Business Angel Network.
Show more...Investment focus
- Industry: Mobile, Sports, FinTech
- Stage:Seed, Angel, Pre-Seed
- Geography: Estonia, Latvia, Norway
Investor stats
- Total investments: 5
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Efenco — Efenco is a deep-tech startup developing patented clean energy conversion technologies, that increase the combustion efficiency of natural gas and hydrogen by unprecedented 18%
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
- Nordic Automation Systems — Nordic Automation Systems (NAS) is an industrial automation company. We believe in the world with precise data and less tedious repetitive manual tasks. We create sensor technologies, data analysis and monitoring solutions.LoRa® technology enables us to provide end-to-end LoRaWAN™ - smart metering, smart monitoring, smart city and industrialIoT applications. NAS has about 25 employees in it's Norwegian and Estonian offices and customers in every continent.
Peep Vain is the Private Investor at Vain and Partners. He attended Bentley University.
Show more...Investment focus
- Industry: Software, Genetics, Recruiting
- Stage:Seed, Angel
- Geography: Estonia
Investor stats
- Total investments: 5
- Round size: Seed $801k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
- Bisly — Bisly is an Estonian startup developing intelligent building solutions.
- Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
UniTartu Ventures team up with early-stage deep tech investors to support the University of Tartu's connected researchers, startups, and spin-off’s growth.
Show more...Investment focus
- Industry: Biotechnology, Nanotechnology
- Stage:Pre-Seed, Seed
- Geography: Estonia
Investor stats
- Total investments: 4
- Round size: Seed $2.6M–$4.3M; Pre-Seed $399k–$543k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- UP Catalyst — UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Siim Sikkut
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Hugues Flament
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series C, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 131
- Round size: Series A $3M–$35M; Series B $15M–$49M; Series C $12M–$40M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- ViaCyte — ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes. Their therapy is based on the differentiation of stem cells into pancreatic beta-cell precursors, with subcutaneous implantation in an encapsulation device. Data in their publications demonstrate that these cells can produce therapeuticallyrelevant levels of insulin in response to blood glucose, and sustain diabetic animals. Their goal is a product which can free both Type 1 and Type 2 patients with diabetes from insulin dependence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications.
- Aduro BioTech — Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. It was founded in 2000 and headquartered in Berkeley, California.
- Ronovo Surgical — Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.
Johanna Britt Berzin
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
AS AMALFI
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 595
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Robert Laud
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
Aare Kurist
Show more...Investment focus
- Industry: Genetics, Biotechnology
- Stage:Seed
- Geography: Estonia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
Estonian Research Council is a government agency that promotes research funding, development, and innovation systems for society.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed
- Geography: Estonia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MYCEEN — MYCEEN is a carbon-negative materials combining mushroom mycelium and industrial byproducts.
- KappaZeta — Kappazeta's AI-driven satellite insights help governments and businesses make fact-baseddecisions and save time on analyzing vast amounts of data globally.
Timo Rein is based out of New York, New York, and is the Co-Founder of Pipedrive. Timo Rein attended the University of Tartu.
Show more...Investment focus
- Industry: Software, Recruiting, Human Resources
- Stage:Seed, Angel, Convertible Note
- Geography: Estonia, Finland, United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $300k–$2M; Angel $136k–$359k
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- YuMuuv — YuMuuv is an employee wellness platform that uses science-based formulas to capture data and keeps track of physical activity & leaderboard.
- Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
- Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!
Biotechnology Investor funding in Estonia at a glance
Stats across 49 deals from 51 investors.
Access all 51 investors in Estonia Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Estonia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 51 investors investing in Estonia Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!